Time New York: Thu 29 Sep 01:04 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

BioSpecifics Technologies (BSTC) Catches Eye: Stock Up 5.2%

Zacks

BioSpecifics Technologies Corp. BSTC moved big last session, as the company saw its shares rise above 5%. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $36.10 to $42.76 in the past one-month time frame.

The company has not seen any estimate revision in the past month and its Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

BioSpecifics Technologies currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.

BIOSPECIFICS TE Price

BIOSPECIFICS TE Price | BIOSPECIFICS TE Quote


Another favorably ranked stock in the healthcare sector is Acerus Pharmaceuticals Corporation TRLPF, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BSTC going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.